Synonyms: CNTO-1959 | Tremfya®
guselkumab is an approved drug (EMA & FDA (2017))
Compound class:
Antibody
Comment: Guselkumab is a monoclonal antibody directed against interleukin-23A (IL23A). It is being investigated as a treatment for plaque psoriasis.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification | |
Compound class | Antibody |
Approved drug? | Yes (EMA & FDA (2017)) |
International Nonproprietary Names | |
INN number | INN |
9774 | guselkumab |
Synonyms |
CNTO-1959 | Tremfya® |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 468 |
Other databases | |
GtoPdb PubChem SID | 249565678 |
Search PubMed clinical trials | guselkumab |
Search PubMed titles | guselkumab |
Search PubMed titles/abstracts | guselkumab |
Wikipedia | Guselkumab |